基本信息
浏览量:67
职业迁徙
个人简介
Dr. Michel Langlois, born in 1967 (Belgium), was trained in Medicine (1985-1992) and Clinical Biology (1992-1997) at the University of Ghent (Belgium). After his PhD defence on the haptoglobin polymorphism (promotor: Prof. Joris Delanghe) in 1997, he was postdoctoral researcher (FWO, Flanders) in 1998-2001. Since 2002, he continued his professional activities in clinical chemistry in AZ St.-Jan Hospital in Bruges, combined with a position of Visiting Professor at University of Ghent in 2009-2023. His area of interest and expertise is lipidology and cardiovascular risk biomarkers.
Michel Langlois is founder and Past-President of the Royal Belgian Society of Laboratory Medicine (RBSLM), Past-President of the Belgian Atherosclerosis Society/Lipid Club, member of the Working Group - Clinical Chemistry (National Scientific Institute of Public Health "Sciensano"), Chair of Science Committee of the European Federation of Laboratory Medicine (EFLM) since 2022, and Associate Editor of the journal Clinical Chemistry – reviews section since 2023. His scientific activities resulted in more than 120 publications in international peer-reviewed journals, 5 scientific awards, and 10 chapters in medical textbooks.
研究兴趣
论文共 127 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical chemistry and laboratory medicineno. 0 (2024)
European Radiologyno. 0 (2023): 1-7
Journal of the American Heart Associationno. 15 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn